Robin Park

10PUBLICATIONS
37CO-AUTHORS
Epidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 12, 2026
Externally Validated Machine Learning Models for 30-/90-/180-Day Unplanned Readmission After Head and Neck Cancer Hospitalizations in the United States.

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Jul 11, 2025
Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy.

Michelle Echevarria, Robin Park, Jimmy J Caudell

|Sep 20, 2024
Advanced Human Papillomavirus-Negative Head and Neck Squamous Cell Carcinoma: Unmet Need and Emerging Therapies.

Robin Park, Christine H Chung

|Jul 29, 2021
The prognostic and predictive impact of BRAF mutations in deficient mismatch repair/microsatellite instability-high colorectal cancer: systematic review/meta-analysis.

Robin Park, Laercio Lopes, Sunggon Lee

|Jun 08, 2021
Current landscape of immunotherapy trials in locally advanced and high-risk head and neck cancer.

Robin Park, Jong Chul Park

Pageof 2

Frequent Collaborators

3 joint publications

Christine H Chung

2 joint publications

Antonio L Amelio

2 joint publications

Ritu Chaudhary

2 joint publications

Kedar Kirtane